The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

SEO
SEO in the Age of AI: What CMOs and CEOs Need to Know About AEO and GEO
November 20, 2025

In an era when AI-driven search experiences are reshaping how customers discover brands, marketing leaders are navigating a confusing landscape of new acronyms, shifting behaviors, and bold industry predictions. Despite widespread claims that “SEO is dead,” the data tells a different story: organic search traffic has continued to grow even as platforms like ChatGPT, Gemini,…

Read More
From the Bench: How Research Can Help Us Build a Future-Ready Global Healthcare Workforce | Lauren Herckis | EP 18
From the Bench: How Research Can Help Us Build a Future-Ready Global Healthcare Workforce
November 20, 2025

The Care Anywhere podcast is taking listeners behind the scenes of global health workforce research with a brand-new series: From the Bench. In this kickoff episode, host Lea Sims talks with Dr. Lauren Herckis of TruMerit about how research can move from data to real-world impact — revealing how evidence, collaboration, and curiosity are driving…

Read More
purpose
Elevate Your Career Journey by Choosing Purpose, Practicing Intentionality, and Building a Culture of Belonging
November 19, 2025

Purpose doesn’t just shape what we do—it shapes how we grow. When we choose to move through our careers with intention, we start noticing the moments that build trust, the conversations that deepen understanding, and the relationships that elevate our impact. This episode of Professional Quotient digs into what it really means to show up…

Read More
Christie Linebarger
Christie Linebarger’s Journey to Leadership: Grit, Growth & Leading with Heart
November 19, 2025

Leadership conversations are shifting as companies navigate rapid change, tighter labor markets, and evolving employee expectations. Teams want leaders who show up with humility, clarity, and a genuine investment in people—traits that can’t be faked and can’t be automated. And with studies consistently linking team engagement to the quality of direct leadership, understanding how effective…

Read More